Radioimmunodetection and Radioimmunotherapy in Myosarcoma
Soft-tissue sarcomas account for approximately 1% of all malignancies. The treatment of choice is surgery, which is the only curative treatment for primary tumors of the trunk, head, and neck primaries. Initially, sarcomas of the limbs had to be treated with amputation, but since the discovery that adjuvant radiotherapy can prevent almost half of the local recurrence in sarcoma of the extremities [1, 2], limb-sparing surgery has become possible.
KeywordsToxicity Iodine Oncol Sarcoma Guanidine
Unable to display preview. Download preview PDF.
- 1.Abbatucci JS, Boulier N, de Ranier J, Mandard AM, Tanguy A, Busson A (1984) Radiotherapy as an integrated part of the treatment of soft tissue sarcomas. Radiother Oncol 2: 115–121Google Scholar
- 2.Rosenberg SA, Tepper J, Glatstein E, Costa J, Baker A, Brennan M, De Moss EV, Seipp C, Sindelar WF, Sugarbaker P, Wesley R (1982) The treatment of soft tissue sarcomas of the ex-tremities. Prospective randomized evaluation of (1) limb sparing surgery plus radiation therapy compared with amputation and (2) the role of adjuvant chemotherapy. Ann Surg 196: 305–315PubMedCrossRefGoogle Scholar
- 3.Rosenberg SA, Chang E, Glatstein E (1985) Adjuvant chemotherapy of extremity soft tissue sarcomas: review of National Cancer Institute experience. Cancer Treat Symp 3: 83–88Google Scholar
- 6.Yap BS, Sinkovics JG, Burgess MA, Benjamin RS, Bodey CP (1983) The curability of advanced soft tissue sarcomas in adults with chemotherapy. Proc ASCO abstr C-937, p 239Google Scholar
- 7.Pinedo HM, Bramwell VHC, Mouridsen HT, Somers R, Vendrik CPJ, Santoro A, Buesa J, Wagener T, v Oosterom AT, v Unnik JAM, Sylvester R, de Pauw M, Thomas D, Bonadonna G (1984) CYVADIC in advanced soft tissue sarcoma: a randomized study comparing two schedules. Cancer 53: 1852–1832Google Scholar